Generated by AI
Bone Biologics Corp. operates in the biotechnology sector, focusing on products that enhance bone growth and regeneration. The company's primary aim is to develop and commercialize NELL-1, a proprietary protein that has shown potential in accelerating bone repair and treating spinal fusion. Bone Biologics targets medical conditions requiring bone regeneration, such as spinal disorders, osteoporosis, and other orthopedic and neurosurgical needs. The innovations by Bone Biologics are poised to influence both the healthcare and biotechnology industries by offering alternatives to existing bone graft solutions. As Bone Biologics continues its research and development efforts, it aims to address critical gaps in surgical outcomes with products that enhance patient recovery.
Website2 Burlington Woods Drive
Burlington, MA, 01803
United States
The latest articles about BBLGW.
Addition of three sites strengthens expectation to complete enrollment by year-end 2026BURLINGTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced that six hospital sites in Australia are now under agreement to participate in its first-in-human pilot clinical trial of NB1, the Company’s rhNELL-1-based bone graft product for spinal fusion. Th
Summary of Nov 28's posts. Generated by AI.
No summary yet.
No summary yet.
BURLINGTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The conference is being held on September 14 – 16, 2026 at the Lotte New York Palace Hotel. Jeff Frelick, Chief Executive Officer of Bone Biologics will hold one-on-one meetings with investors
No summary yet.
No summary yet.
Investors talking about BBLGW also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.